Evidence map›Paper›PMID 26312580›Full record

Trial reportThe Journal of clinical endocrinology and metabolism2015

Free 25(OH)D and Calcium Absorption, PTH, and Markers of Bone Turnover.

John Aloia, Ruban Dhaliwal, Mageda Mikhail, Albert Shieh, Alexandra Stolberg, Louis Ragolia, Melissa Fazzari, Steven A Abrams

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical endocrinology and metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Vitamin D and the Kidney: Two Players, One Console.International journal of molecular sciences · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

John AloiaWinthrop University Hospital, Mineola, New York 11501.
Ruban DhaliwalWinthrop University Hospital, Mineola, New York 11501.
Mageda MikhailWinthrop University Hospital, Mineola, New York 11501.
Albert ShiehWinthrop University Hospital, Mineola, New York 11501.
Alexandra StolbergWinthrop University Hospital, Mineola, New York 11501.
Louis RagoliaWinthrop University Hospital, Mineola, New York 11501.
Melissa FazzariWinthrop University Hospital, Mineola, New York 11501.
Steven A AbramsWinthrop University Hospital, Mineola, New York 11501.
Winthrop-University Hospital · US

Funding

Vitamin D and Osteoporosis Prevention in Elderly African AmericansR01AG032440 · NIA · NYU WINTHROP HOSPITAL · PI ALOIA, JOHN F. · 2010 to 2014
$3.4M
NIA NIH HHS R01 AG032440NIA NIH HHS R01-AG032440-01A2
6 · The paper itself

Abstract

contextIt has been proposed that serum free 25-hydroxyvitamin D [25(OH)D] may better reflect vitamin D action than total 25(OH)D. An ELISA for serum free 25(OH)D has recently become available, permitting direct assay.

objectiveTo determine whether serum free 25(OH)D provides additional information in relation to calcium absorption and other biomarkers of vitamin D action compared to total serum 25(OH)D.

settingAmbulatory research setting in a teaching hospital. OUTCOME: Serum free 25(OH)D measured in a previously performed study of varied doses of vitamin D3 (placebo and 800, 2000, and 4000 IU) on calcium absorption, PTH, procollagen type 1 N-terminal propeptide, and C-terminal telopeptides of type I collagen. Free 25(OH)D was measured by ELISA. Calcium absorption was measured at baseline and at 10 weeks using stable dual calcium isotopes.

resultsSeventy-one subjects completed this randomized, placebo-controlled trial. Baseline group mean free and total 25(OH)D varied from 4.7 ± 1.8 to 5.4 ± 1.5 pg/mL, and from 23.7 ± 5.9 to 25.9 ± 6.1 ng/mL, respectively. Participants assigned to the 4000-IU dose arm achieved free 25(OH)D levels of 10.4 pg/mL and total 25(OH)D levels of 40.4 ng/mL. Total and free 25(OH)D were highly correlated at baseline and after increasing vitamin D dosing (r = 0.80 and 0.85, respectively). Free 25(OH)D closely reflected changes in total 25(OH)D. PTH was similarly correlated at baseline and follow-up with total and free 25(OH)D. Serum C-terminal telopeptides of type I collagen had a moderate positive correlation with total and free 25(OH)D at follow-up. The serum 1,25-dihydroxyvitamin D change increased significantly with the change in 25(OH)D but not with the change in free 25(OH)D.

conclusionThere was no advantage from measuring free over total 25(OH)D in assessing the response of calcium absorption, PTH, and markers of bone turnover to vitamin D. Free 25(OH)D responded to increasing doses of vitamin D in a similar fashion to total 25(OH)D.

Indexed as

Bone RemodelingAdultAgedBiomarkersBone and BonesCalciumCollagen Type IDose-Response Relationship, DrugFemaleHumansHydroxycholecalciferolsMaleMiddle AgedParathyroid HormoneVitaminsYoung AdultBiomarkersCalciumCollagen Type IHydroxycholecalciferolsParathyroid HormoneVitamins

Identifiers

PMID26312580
PMCPMC4702446
OpenAlexW2174133727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.